Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1

Yuan Si1, Xinyan Ji1, Xiaolei Cao1

  • 1Life Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, Zhejiang, China.

Cancer Research
|July 30, 2017
PubMed

Insights

The Src kinase phosphorylates LATS1, a tumor suppressor, impacting the Hippo pathway. This regulates YAP, a key factor in cell growth, and contributes to cancer development.

Area of Science:

  • Cell biology
  • Molecular oncology
  • Signal transduction

Background:

  • The Hippo pathway is crucial for organ size control, regulating cell proliferation and apoptosis.
  • Deregulation of the Hippo pathway is implicated in human cancers, but mechanisms remain unclear.
  • Cell adhesion influences Hippo pathway activity, but the precise molecular links are not fully elucidated.

Purpose of the Study:

  • To investigate the molecular mechanisms linking cell adhesion to Hippo pathway regulation.
  • To identify kinases that phosphorylate LATS1, a key tumor suppressor in the Hippo pathway.
  • To understand the role of Src-mediated LATS1 phosphorylation in tumorigenesis and YAP activation.

Main Methods:

  • Tyrosine kinase library screening to identify LATS1-interacting kinases.
  • In vitro kinase assays to confirm Src-mediated phosphorylation of LATS1.
  • Analysis of LATS1 structure, Mob kinase binding, and YAP activity.
  • Correlation studies in human breast cancer tissues.

Main Results:

  • Src was identified as a direct tyrosine kinase phosphorylating LATS1.
  • Src-mediated LATS1 phosphorylation inhibits its binding to Mob kinase and alters its substrate-binding pocket.
  • Cell adhesion activates YAP via Src-mediated LATS1 inhibition.
  • Aberrant Src activation promotes tumorigenesis in a YAP-dependent manner.
  • Src levels correlate with active YAP in human breast cancers.

Conclusions:

  • Tyrosine phosphorylation of LATS1 by Src is a novel mechanism regulating the Hippo pathway in response to cell adhesion.
  • Src activation contributes to YAP deregulation and tumorigenesis in cancers.
  • This study reveals a new link between cell adhesion, Src signaling, and the Hippo pathway in cancer development.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.3K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
10.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K